Article
Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung…
Drug Design, Development and Therapy · 2022 · Huo R, Guo Q, Hu J, Li N, Gao R, Mi L, Zhang Z, Liu H, Guo Z, Zhao H, Zhang L, Xu K
Key facts
| Title | Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease |
|---|---|
| First author | Huo R, Guo Q, Hu J, Li N, Gao R, Mi L, Zhang Z, Liu H, Guo Z, Zhao H, Zhang L, Xu K |
| Journal | Drug Design, Development and Therapy |
| Published | Apr 2, 2022 |
| DOI | 10.2147/DDDT.S353494 |
| Devices mentioned | 210911, 216983 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1